Log in
Enquire now
‌

US Patent 7186797 Polypeptide conjugates with extended circulating half-lives

Patent 7186797 was granted and assigned to EPIX Pharmaceuticals, Inc. on March, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
‌
EPIX Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
71867970
Patent Inventor Names
Stephane Dumas0
Andrew Kolodziej0
Theodore R. West0
Thomas J McMurry0
Date of Patent
March 6, 2007
0
Patent Application Number
104870250
Date Filed
August 9, 2002
0
Patent Citations Received
‌
US Patent 12076366 Therapeutic vitamin D conjugates
0
Patent Primary Examiner
‌
Jeffrey Edwin Russel
0
Patent abstract

The present invention relates to compounds and methods for synthesizing compounds wherein the compounds exhibit extended circulating half-life in the blood. The increase in circulating half-life is achieved by conjugating polypeptides to binding groups that exhibit high affinity for human serum albumin.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7186797 Polypeptide conjugates with extended circulating half-lives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.